KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

NovoCure (NVCR) Net Margin (2016 - 2025)

Historic Net Margin for NovoCure (NVCR) over the last 12 years, with Q3 2025 value amounting to 22.29%.

  • NovoCure's Net Margin fell 25800.0% to 22.29% in Q3 2025 from the same period last year, while for Sep 2025 it was 27.66%, marking a year-over-year decrease of 17300.0%. This contributed to the annual value of 27.86% for FY2024, which is 127900.0% up from last year.
  • Per NovoCure's latest filing, its Net Margin stood at 22.29% for Q3 2025, which was down 25800.0% from 25.28% recorded in Q2 2025.
  • NovoCure's Net Margin's 5-year high stood at 3.06% during Q1 2021, with a 5-year trough of 45.55% in Q2 2023.
  • In the last 5 years, NovoCure's Net Margin had a median value of 22.2% in 2024 and averaged 24.05%.
  • Its Net Margin has fluctuated over the past 5 years, first plummeted by -400500bps in 2023, then skyrocketed by 233500bps in 2024.
  • NovoCure's Net Margin (Quarter) stood at 19.86% in 2021, then plummeted by -46bps to 29.05% in 2022, then dropped by -21bps to 35.19% in 2023, then decreased by -16bps to 40.88% in 2024, then soared by 45bps to 22.29% in 2025.
  • Its Net Margin was 22.29% in Q3 2025, compared to 25.28% in Q2 2025 and 22.14% in Q1 2025.